BiotechTube
Home/OncoTracker/James R. Berenson, MD
JR

James R. Berenson, MD

Founder and Chief Scientific Officer

OncoTracker

Therapeutic Areas

OncologyHematology

OncoTracker Pipeline

DrugIndicationPhase
sBCMA Testing ServiceMultiple Myeloma MonitoringService
JAK Inhibitor CombinationsMultiple Myeloma & CancersPre-clinical
Gamma Secretase Inhibitor CombinationsMultiple Myeloma (BCMA therapy potentiator)Pre-clinical

Leadership Team at OncoTracker

JY
Jessica Yataco, MBA
Chief Operating Officer
View full OncoTracker profile